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linear regression analysis of initial velocity vs. donor substrate concentration using KaleidaGraph (version 4.1.2).
Chemoenzymatic Labeling on the Glycan Array. Glycan Array version 5.0 was provided by the Consortium for Functional Glycomics (CFG). Pre-equilibrated arrays were treated with BgtA enzyme (0.16 mg/mL) and 500 µM UDP-GalNAz 2 in 20 mM Tris•HCl pH 7.4, 50 mM NaCl, 2 mM MnCl 2 containing 1% bovine serum albumin (BSA) for various times (0, 0.5, 2, and 12 h) at rt, washed 4 times with wash buffer (20 mM Tris•HCl pH 7.4, 50 mM NaCl, 0.1% Triton X-100) and then 4 times with rinse buffer (20 mM Tris•HCl pH 7.4, 50 mM NaCl). The arrays were then incubated with ADIBO-biotin (5 µM) in 20 mM Tris•HCl pH 7.4, 50 mM NaCl for 2 h at rt. After washing as described above, the arrays were washed further with 20% aqueous MeOH and then incubated with streptavidin Cy-5 (0.5 µg/mL; eBioScience) in 20 mM Tris•HCl pH 7.4, 50 mM NaCl, 0.05% Tween-20, 1% BSA, for 1 h at rt. The arrays were then washed 4 times with wash buffer (containing 0.05% Tween-20 instead of 0.1% Triton X-100), 4 times with rinse buffer, 4 times with water, dried under a low stream of filtered air, and scanned using a PerkinElmer ScanArray Express fluorescence scanner and ImaGene data analysis software (BioDiscovery). Data were analyzed per the guidelines of the CFG. 3 The background fluorescence for each spot was determined as the fluorescence signal outside of the area designated as a positive spot on the array. Because background fluorescence can be heterogeneous across the array, each array was divided into areas of 10 by 10 spots, or sub-arrays, and a background fluorescence value was calculated within each sub-array by the software. This value was then subtracted from the fluorescence signal for each glycan spot within the sub-array by the software.
Note that each glycan is printed six different times on the array. To calculate the relative fluorescence intensity for a given glycan, the highest and lowest intensities for each glycan were discarded, and the mean and standard deviation of four fluorescence intensities were calculated. All microarray data will
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be uploaded on the Consortium of Functional Glycomics website (www.functionalglycomics.org) upon publication.
Chemoenzymatic Labeling of Cell Lysates. The olfactory bulbs of postnatal day 3 rat pups were dissected on ice and lysed in boiling 1% SDS (5 volumes/weight) with sonication until the mixture was homogeneous. Protein was precipitated using methanol/chloroform/water. Briefly, protein was diluted to 200 µL and precipitated by sequential mixing with 600 µL of MeOH, 200 µL of CHCl 3 and 450 µL H 2 O, after which the mixture was centrifuged at 23,000 x g for 15 min. Precipitated protein was washed with 450 µL of MeOH and centrifuged at 23,000 x g for 10 min. After the protein pellet was allowed to dry briefly, the pellet was re-dissolved at 5 mg/mL in 20 mM HEPES pH 7.9 containing 1% SDS, and diluted 5-fold into a buffer with the following final concentrations: 20 mM HEPES pH 7.9, 50 mM NaCl, 2% NP-40, 5 mM MnCl 2 . UDP-GalNAz 2 (25 µM; Invitrogen) and BgtA (0.16 mg/mL) were added, and the samples were incubated at 4 °C for 16-20 h. The labeled proteins were precipitated as above and resuspended in 50 mM Tris pH 7.4 containing 1% SDS at 4 mg/mL.
The resuspended proteins were subsequently reacted with alkyne-TAMRA 10 (Invitrogen) or alkyne-biotin 11 (Invitrogen) as per the Click-It™ TAMRA and Biotin Glycoprotein Detection Kit (Invitrogen) instructions, except that EDTA-free Complete™ protease inhibitors were added during the reaction. For TAMRA labeling, negative controls were performed under identical conditions except that BgtA, UDP-GalNAz 2, or alkyne-TAMRA 10 was omitted from the labeling reaction. For biotin labeling, negative controls were performed under identical conditions except that BgtA was omitted from the labeling reaction. After the labeling reactions, protein was precipitated using chloroform/methanol/water as described above and re-dissolved in boiling 2% SDS. This precipitation and resolubilization was then repeated once more to ensure removal of non-specific interactions.
TAMRA-labeled proteins were resolved by SDS-PAGE and visualized in-gel using a Typhoon
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Scanner (GE Healthcare). Interestingly, BgtA itself was labeled, and attempts to remove the signal by precipitation or heat and detergent denaturation were unsuccessful, suggesting covalent modification of the protein. Protein eluates were concentrated to a volume of 100 µL using a Vivaspin 500 spin filter (10,000 Da MWCO). Following concentration, samples were boiled in 1X sample buffer (35 µL of 200 mM Tris pH 6.8, 400 mM DTT, 8% SDS, 0.2% bromophenol blue, and 40% glycerol) and analyzed by SDS-PAGE and western blotting as described above. Synapsin I was detected using mouse anti-synapsin I ascites (Synaptic Systems) at 0.1 µg/mL.
Purification of
Cell Culture. HeLa, MCF-7, and MDA-mb-231 cells grown in DMEM medium supplemented with 10% fetal bovine serum (FBS), 100 units/mL penicillin, and 0.1 mg/mL streptomycin (Gibco). LNCaP
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and H1299 cells were grown in RPMI medium 1640 supplemented with 10% FBS, 100 units/mL penicillin, and 0.1 mg/mL streptomycin (Gibco). The PrEC line was maintained in PrEBM medium (Lonza). All transfections were carried out in antibiotic-free media. In all cases, cells were incubated in a 5% CO 2 humidified chamber at 37 °C. The PrEC line was obtained from Lonza; all other cell lines were obtained from ATCC.
Immunoprecipitation of TAMRA-Labeled Synapsin I from HeLa Cell Lysates. HeLa cells were transfected with pCMV-FLAG-synapsin Ia 4 using Lipofectamine LTX reagent (Invitrogen). The cells were lysed and chemoenzymatically labeled and protein was precipitated as described above. After the protein pellet was allowed to dry briefly, the pellet was re-dissolved in boiling 1% SDS plus
Complete™ protease inhibitors at a concentration of 2 mg/mL. The SDS was quenched with 1 volume of NETFD buffer plus protease inhibitors, and the lysate was incubated with 40 µL of prewashed antiFlag M2 Affinity Gel (Sigma-Aldrich) for 90 min at 4 °C. The resin was washed once with 4 column volumes of NETFD buffer and three times with 4 column volumes of NETF buffer (100 mM NaCl, 50 mM Tris•HCl pH 7.4, 5 mM EDTA). Captured protein was eluted in boiling 2X sample buffer (50 µL buffer/100 µL resin). Purified, labeled material was resolved by SDS-PAGE and transferred to a polyvinylidene fluoride (PVDF) membrane (Millipore). Western blotting was performed as above except the primary anti-TAMRA rabbit antibody (0.1 µg/µL; Invitrogen) was used.
Detection of Cell-Surface Fuc (1-2)Gal Glycans on Live MCF-7 Cells by Fluorescence
Microscopy. MCF-7 cells (ATCC) were seeded at 2 x 10 5 cells/coverslip. Twelve hours after plating, the cells were washed twice with 1% FBS, 10 mM HEPES in calcium and magnesium free Hank's Balanced Salt Solution (CMF HBSS, Gibco) and incubated in the chemoenzymatic labeling buffer (2% FBS, 10 mM HEPES pH 7.9 in HBSS) with UDP-GalNAz 2 (500 µM) and BgtA (0.17 mg/mL) in a S10 total volume of 100 µL for 2 h at 37 ºC. Mock reactions were performed without the addition of BgtA. Figure S9 . Comparison of UEAI lectin affinity chromatography to the chemoenzymatic strategy. Glycosylated synapsin I from olfactory bulb lysate (500 µg) was subjected to lectin affinity chromatography or chemoenzymatic labeling followed by streptavidin capture. Western blotting for synapsin I indicated that UEAI failed to capture and detect glycosylated synapsin I, whereas the chemoenzymatic strategy allowed for ready detection. 
